Force analgésique à action rapide


Vetonixin is indicated for the control of pyrexia associated with bovine respiratory disease (BRD), endotoxemia and acute bovine mastitis. Vetonixin is also indicated for the control of inflammation associated with endotoxemia. In clinical studies, flunixin as an adjunct to antibiotic therapy with oxytetracycline has been demonstrated to control pyrexia associated with bovine respiratory disease.



Flunixin meglumine is a potent, non-narcotic, non-steroidal analgesic agent with anti-inflammatory activity. Antipyretic activity has been demonstrated in cattle and laboratory animals. It is significantly more potent than pentazocine, meperidine and codeine as an analgesic in the rat yeast paw test.

Flunixin 50 mg/mL [as meglumine USP]


Available in 100 mL and 250 mL bottles.

Store Vetonixin below 25 °C.

Access the Compendium

For more information on Vetoquinol products and labels, please visit the Compendium website

Safety Data Sheets

To view the Vetoquinol products safety data sheets, please click here